NCT03999151

Brief Summary

The Prostate 8-II study is a randomized controlled trial of testing different combinations of educational and supportive tools related to diet and exercise to evaluate biological, clinical, and quality of life outcomes in men choosing radical prostatectomy as treatment for prostate cancer.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
204

participants targeted

Target at P50-P75 for not_applicable prostate-cancer

Timeline
26mo left

Started May 2018

Longer than P75 for not_applicable prostate-cancer

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
May 2018Aug 2028

Study Start

First participant enrolled

May 11, 2018

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

June 21, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 26, 2019

Completed
9.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2028

Last Updated

July 16, 2026

Status Verified

July 1, 2026

Enrollment Period

10.3 years

First QC Date

June 21, 2019

Last Update Submit

July 14, 2026

Conditions

Keywords

ExerciseDietLifestyleDigitalText messagingCoach

Outcome Measures

Primary Outcomes (1)

  • Median Time to prostate-specific antigen recurrence

    The median time in months to PSA recurrence after surgery will be evaluated using prespecified biochemical recurrence (2x PSA ≥ 0.2) and detectable (2x PSA ≥ 0.03) PSA thresholds, at the time of analysis. A log-rank test to evaluate the time to recurrence among groups and multivariate Cox proportional hazards regression will be used to obtain a hazard ratio for the time to recurrence.

    Up to 5 years post-surgery

Secondary Outcomes (12)

  • Proportion of participants with PSA recurrence over time

    Up to 24 months post-surgery

  • Mean scores on the Expanded Prostate Cancer Index Composite Short Form (EPIC-26) over time.

    Baseline, and 6 months, 12 months, and 24 months post-surgery

  • Mean scores on the urinary function domain of the EPIC-26 over time.

    Baseline, and 6 months, 12 months, and 24 months post-surgery

  • Mean scores on the general anxiety scale of the Patient-Reported Outcomes Measurement Information System (PROMIS) over time.

    Baseline, and 6 months, 12 months, and 24 months post-surgery

  • Mean scores on the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) over time.

    Baseline, and 6 months, 12 months, and 24 months post-surgery

  • +7 more secondary outcomes

Study Arms (4)

Arm A: Reference Group

ACTIVE COMPARATOR

Arm A will receive print educational materials about the benefits of exercise and diet for men with prostate cancer, with recommendations geared at men living with prostate cancer, mailed around the date of surgery. They also receive a 10-week text messaging program focused on recovery after radical prostatectomy surgery.

Behavioral: Exercise and Diet

Arm B (Arm A + Exercise)

EXPERIMENTAL

Arm B receives the following: Arm A material plus access to an online portal with additional educational materials to help improve exercise habits and various tools, such as the ability to track exercise; additional educational print materials on exercise; additional text messages over 2 years that supports healthy exercise habits; and a 1-hour phone session at the start of the study followed by eight 30-minute quarterly phone sessions with an exercise coach over 2 years.

Behavioral: Exercise and Diet

Arm C (Arm A + Diet)

EXPERIMENTAL

Arm C receives the following: Arm A material plus access to an online portal with additional educational materials to help improve diet habits and various tools, such as the ability to track diet; additional educational print materials on diet; additional text messages over 2 years that supports healthy diet habits; and a 1-hour phone session at the start of the study followed by eight 30-minute quarterly phone sessions with a diet coach over 2 years.

Behavioral: Exercise and Diet

Arm D (Arm A + Exercise + Diet)

EXPERIMENTAL

Arm D receives the following: Arm A material plus access to an online portal with additional educational materials to help improve exercise and diet habits and various tools, such as the ability to track exercise and diet; additional educational print materials on exercise and diet; additional text messages over 2 years that supports healthy exercise and diet habits; a 1-hour phone session at the start of the study followed by eight 30-minute quarterly phone sessions with an exercise coach over 2 years; and a 1-hour phone session at the start of the study followed by eight 30-minute quarterly phone sessions with a diet coach over 2 years.

Behavioral: Exercise and Diet

Interventions

Behavioral program provides access to educational materials + clinical texting program (Arm A) + participant portal, text messaging, and coaching (Arms B-D)

Arm A: Reference GroupArm B (Arm A + Exercise)Arm C (Arm A + Diet)Arm D (Arm A + Exercise + Diet)

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>=18 years
  • Diagnosed with non-metastatic prostate cancer and choose radical prostatectomy (RP) as primary treatment.
  • Able to speak and read English
  • Regular access to the Internet (via a computer, tablet, or phone) and text messaging capabilities on the phone
  • Ability to understand a written informed consent document, and the willingness to sign it

You may not qualify if:

  • Cannot have neoadjuvant radiation or hormone therapy planned at time of enrollment (if enrolling \>4 weeks prior to RP).
  • Men who have contraindications to exercise based the American College of Sports Medicine 2016 Exercise pre-participation screening criteria (https://www.ncbi.nlm.nih.gov/pubmed/26473759), and who do not receive a physician clearance to participate in the moderate to vigorous intensity physical activity with one or more of the following self-reported conditions:
  • Heart attack
  • Heart surgery, cardiac catheterization, or coronary angioplasty
  • Pacemaker/implantable cardiac defibrillator/rhythm disturbance
  • Heart valve disease
  • Heart failure
  • Heart transplantation
  • Congenital heart disease
  • Diabetes
  • Kidney (renal) disease
  • Chest discomfort with exertion
  • Unreasonable breathlessness
  • Dizziness, fainting, or blackouts
  • Ankle swelling
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, San Francisco (UCSF)

San Francisco, California, 94143, United States

Location

MeSH Terms

Conditions

Prostatic NeoplasmsMotor Activity

Interventions

ExerciseDiet

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Stacey A Kenfield, DSc

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2019

First Posted

June 26, 2019

Study Start

May 11, 2018

Primary Completion (Estimated)

August 31, 2028

Study Completion (Estimated)

August 31, 2028

Last Updated

July 16, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations